CFO Tobin Schilke sold $98K of Revance Therapeutics, Inc.

Sold$98,070

$30.64Price

3,201Shares

−4%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Thu, Jun 1. Filed Mon, Jun 5, 2:06 PM ET, during the session. Not investment advice.